Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Time for a Model Upgrade

CMOs' business model has all of the flaws of the captive model it is meant to replace.
Mar 2, 2010

CMOs' business model has all of the flaws of the captive model it is meant to replace.

A Look Ahead for 2010

Some predictions for contract services in 2010.
Feb 3, 2010

Some predictions for contract services in 2010.

Squeezed for Cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Jan 6, 2010

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

A Look Ahead for 2010

Some predictions for contract services in 2010.
Jan 2, 2010

Some predictions for contract services in 2010.

The year ahead

Some predictions about what's in store for contract services in 2010.
Jan 1, 2010

It's customary among columnists to begin a new year with some predictions about what's to come. We don't honour that custom every year, but with what the contract services industry went through in 2009, it seemed appropriate to share thoughts on what we expect for 2010.

Squeezed for Cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Dec 2, 2009

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

Facing Reality

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.
Dec 2, 2009

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.

Squeezed for cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Dec 1, 2009

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

The Outlook for Contract Services: Is That Light at the End of the Tunnel?

Nov 24, 2009

View Jim Miller's presentation from the AAPS 2009 Meeting and Exhibition.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here